Cellectar Biosciences Inc (CLRB)

[petergriffin]

That news was bad but it was not quite as bad as the market drop suggested. The primary endpoint was not met but from what I understand it was not exactly by a huge distance and had more to do with the data which came out of the control arm. I still believe they are onto something with their drugs, better news is coming and this stock is way oversold. JMO.